| ★ | Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | | 199 | Estados Unidos | |
| 1 | Phase 3 VISIONARY: Sibeprenlimab May Preserve #KidneyFunction in IgA Nephropathy | | 981 | Estados Unidos | 91 |
| 4 | Nefropatía por IgA en adultos Una revisión actualizada | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 690 | — | 88 |
| 17 | CORE Truths about Kidney Health | | 512 | Estados Unidos | 86 |
| 9 | SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 87 |
| 11 | Where Kidney Biopsy Is Heading Next I #IgA Nephropathy Care | | 366 | Estados Unidos | 87 |
| 3 | Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy | | 233 | Estados Unidos | 91 |
| 14 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 86 |
| 10 | Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies | | 109 | Estados Unidos | 87 |
| 16 | GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | 86 |
| 13 | DUPLEX Trial Results: Key Insights in #FSGS | | 71 | Estados Unidos | 86 |
| 15 | Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD | | 60 | Estados Unidos | 86 |
| 12 | Why Does IgA Nephropathy Affect More Men? With Ramy Hanna, MD | | 52 | Estados Unidos | 87 |
| 2 | B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD | | 27 | Estados Unidos | 91 |
| 18 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 86 |
| 5 | Helping Patients with IgAN Navigate Treatment Decisions | | 7 | Estados Unidos | 87 |
| 7 | The Pathologist’s Role in IgAN Management | | 6 | Estados Unidos | 87 |
| 8 | The Pathologist’s Role in IgAN Management | | 6 | Estados Unidos | 87 |
| 20 | Seeking Expert Opinions in IgAN Care | | 6 | Estados Unidos | 86 |
| 19 | Seeking Expert Opinions in IgAN Care | | 3 | Estados Unidos | 86 |
| 6 | Helping Patients with IgAN Navigate Treatment Decisions | | 2 | Estados Unidos | 87 |